Skip to main content
OpenTrials
Completed

NCT Number: NCT00000248

Dose Response Trial of Pergolide for Cocaine Dependence - 1

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

21 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Medical University of South Carolina

Charleston, South Carolina, 29425 742, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Pergolide

Drug

Primary outcomes

  1. Side effects

  2. Drug use

  3. Retention

  4. Cocaine withdrawal

  5. Compliance

  6. Effectiveness of medication for global improvements

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Dose Response Trial of Pergolide for Cocaine Dependence

Important dates

Study start
1996
First posted
Sep 21, 1999
Registry last updated
May 16, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.